Autres langues Autolus Therapeutics plc

Actions

AUTL

US05280R1005

Produits pharmaceutiques

Marché Fermé - 22:00:00 02/09/2026 Varia. 5j. Varia. 1 janv.
2,240 USD -3,03% Graphique intraday de Autolus Therapeutics plc -3,86% +12,56%

Autres langues

28/08 European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
27/08 European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading
26/08 European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
24/08 European Equities Traded in the US as American Depositary Receipts Track Slightly Lower in Monday Trading
21/08 European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading
20/08 European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
19/08 European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
17/08 European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
14/08 European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading
13/08 European Equities Traded in the US Rise in Thursday Trading
11/08 European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
11/08 Autolus Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
11/08 Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
11/08 Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
07/08 European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
06/08 European Equities Traded in the US as American Depositary Receipts Track Higher in Thursday Trading
04/08 European Equities Traded in US as ADRs Advance in Tuesday Trading
03/08 Autolus Therapeutics to Report Second Quarter 2026 Financial Results and Host Conference Call on August 11, 2026
03/08 European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
03/08 Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors
03/08 Autolus Therapeutics plc Raises Earnings Guidance for Fiscal Year 2026
03/08 Autolus Therapeutics Plc Enters Into $250 Million Senior Secured Notes Facility With Perceptive Credit Holdings V, LP
27/07 European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading
24/07 European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
21/07 European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Aucun résultat pour cette recherche